A population pharmacokinetics and pharmacodynamic approach to optimize tazobactam activity in critically ill patients

SN Kalaria, M Gopalakrishnan… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
The percentage of the time that the free drug concentration remains above a concentration
threshold (% fT> concentration threshold) has frequently been identified to be the optimal …

Pharmacoeconomics of continuous versus intermittent infusion of piperacillin–tazobactam for the treatment of complicated intraabdominal infection

CA DeRyke, JL Kuti, D Mansfield… - American journal of …, 2006 - academic.oup.com
Piperacillin sodium–tazobactam sodium, a β-lactam antimicrobial, is extensively used
because of its broad-spectrum activity against many enteric gram-negative pathogens …

Clinical and economic impact of empirical extended-infusion piperacillin-tazobactam in a community medical center

L Brunetti, S Poustchi, D Cunningham… - Annals of …, 2015 - journals.sagepub.com
Background: Current medical center practice allows for the automatic conversion of all
piperacillin/tazobactam orders from intermittent to extended infusion (EI). Objective: To …

Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam

MA Pfaller, AL Barry, PC Fuchs, EH Gerlach… - European Journal of …, 1992 - Springer
Piperacillin combined with tazobactam was tested at both a fixed ratio (8: 1) and fixed
tazobactam concentration (4 µg/ml) against 2,685 consecutively isolated gram-negative …

Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.

T Dalla Costa, A Nolting, K Rand… - International journal of …, 1997 - europepmc.org
Purpose The aim of the study was to investigate the in vitro antiinfective effect of piperacillin-
tazobactam (PIP-TZB) combinations on Escherichia coli in simulations of free concentration …

Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation

YK Kim, HS Kim, S Park, H Kim… - Journal of …, 2022 - academic.oup.com
Objectives To explore extracorporeal membrane oxygenation (ECMO)-related alterations of
the pharmacokinetics (PK) of piperacillin/tazobactam and determine an optimal dosage …

Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection

FJ Legat, R Krause, P Zenahlik… - Antimicrobial agents …, 2005 - Am Soc Microbiol
We investigated the pharmacokinetics of piperacillin and tazobactam in the extracellular
space fluid of inflamed soft tissues of six patients with diabetic foot infection using in vivo …

[HTML][HTML] Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2023 - mdpi.com
(1) Background: Piperacillin-tazobactam represents the first-line option for treating infections
caused by full-or multi-susceptible Enterobacterales and/or Pseudomonas aeruginosa in …

National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers

EJ Baron, RN Jones - Diagnostic microbiology and infectious disease, 1995 - Elsevier
Hospital microbiology laboratories from 41 states participated in a bacterial antimicrobial
susceptibility study comparing in vitro results generated by the standardized disk diffusion …

Piperacillin: human pharmacokinetics after intravenous and intramuscular administration

TB Tjandramaga, A Mullie, R Verbesselt… - Antimicrobial agents …, 1978 - Am Soc Microbiol
The pharmacokinetics of piperacillin were studied in a total of 26 Caucasian normal male
volunteers. Single intramuscular doses of 0.5, 1.0, and 2.0 g were given to three groups …